| scholarly article | Q13442814 |
| P2093 | author name string | Ivet Bahar | |
| Bing Liu | |||
| Hongchun Li | |||
| Fen Pei | |||
| P2860 | cites work | Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices | Q48465187 |
| Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration | Q48616683 | ||
| Relationship between subjective effects of cocaine and dopamine transporter occupancy | Q48725518 | ||
| Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus | Q48846262 | ||
| Analyzing the genes related to nicotine addiction or schizophrenia via a pathway and network based approach | Q49870570 | ||
| Essential role of the NO signaling pathway in the hippocampal CA1 in morphine-associated memory depends on glutaminergic receptors. | Q50548115 | ||
| Antisocial personality disorder and aggression in recently abstinent cocaine dependent subjects. | Q51546174 | ||
| Heroin Abuse Results in Shifted RNA Expression to Neurodegenerative Diseases and Attenuation of TNFα Signaling Pathway. | Q55318519 | ||
| The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. | Q55331780 | ||
| Autophagy in idiopathic pulmonary fibrosis | Q21134133 | ||
| Addictive Drugs and Brain Stimulation Reward | Q22241983 | ||
| Drug-target interaction prediction: databases, web servers and computational models | Q38568763 | ||
| Atg5- and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine | Q38655315 | ||
| mTOR Signaling in Growth, Metabolism, and Disease. | Q38747508 | ||
| The Role of NFkB in Drug Addiction: Beyond Inflammation. | Q38775455 | ||
| An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. | Q39696852 | ||
| Molecular Mechanisms of Drug Reinforcement and Addiction | Q40441120 | ||
| Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway. | Q40677598 | ||
| Nanoconnectomic upper bound on the variability of synaptic plasticity | Q41914467 | ||
| Interaction of intravenous anesthetics with recombinant human M1-M3 muscarinic receptors expressed in chinese hamster ovary cells. | Q42528251 | ||
| Predicting drug-target interactions using probabilistic matrix factorization | Q42778934 | ||
| Significance of p53 dynamics in regulating apoptosis in response to ionizing radiation, and polypharmacological strategies | Q42852757 | ||
| Activation of phosphatidylinositol 3-kinase/Akt-mammalian target of Rapamycin signaling pathway in the hippocampus is essential for the acquisition of morphine-induced place preference in rats | Q42913425 | ||
| Toward more realistic drug-target interaction predictions | Q43191660 | ||
| Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization | Q44219446 | ||
| Endogenous opioid systems: current concepts and clinical correlations | Q44335649 | ||
| Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors | Q44343196 | ||
| Sigma opioid receptor: characterization and co-identity with the phencyclidine receptor | Q44346012 | ||
| The inhibitory effects of ketamine and pentobarbital on substance p receptors expressed in Xenopus oocytes | Q44486048 | ||
| Role for M5 muscarinic acetylcholine receptors in cocaine addiction. | Q44586813 | ||
| Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts. | Q45996025 | ||
| Fentanyl induces autophagy via activation of the ROS/MAPK pathway and reduces the sensitivity of cisplatin in lung cancer cells | Q46471542 | ||
| Quantitative assessment of cell fate decision between autophagy and apoptosis | Q47110911 | ||
| DrugBank 5.0: a major update to the DrugBank database for 2018. | Q47128239 | ||
| mTORC1 as the main gateway to autophagy | Q47301187 | ||
| Connecting Neuronal Cell Protective Pathways and Drug Combinations in a Huntington's Disease Model through the Application of Quantitative Systems Pharmacology. | Q47564614 | ||
| Rapamycin prevents drug seeking via disrupting reconsolidation of reward memory in rats | Q47963921 | ||
| The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity | Q22242368 | ||
| Cellular basis of memory for addiction | Q24615131 | ||
| Neurocircuitry of addiction | Q24647156 | ||
| Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice | Q24650110 | ||
| Norepinephrine and stimulant addiction | Q24656833 | ||
| Neurobiologic Advances from the Brain Disease Model of Addiction | Q26774129 | ||
| The Brain on Drugs: From Reward to Addiction | Q26798096 | ||
| The neurology of mTOR | Q26824286 | ||
| Neuronal gap junctions: making and breaking connections during development and injury | Q26825282 | ||
| Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder | Q27015917 | ||
| Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes | Q28199192 | ||
| The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans | Q28236333 | ||
| Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling | Q28253698 | ||
| Dopaminergic neurons inhibit striatal output through non-canonical release of GABA | Q28276335 | ||
| Striatal signal transduction and drug addiction | Q28392093 | ||
| Genes and (common) pathways underlying drug addiction | Q28471939 | ||
| Involvement of mitogen-stimulated p70-S6 kinase in the development of sensitization to the methamphetamine-induced rewarding effect in rats | Q28575201 | ||
| Neural systems of reinforcement for drug addiction: from actions to habits to compulsion | Q29547251 | ||
| Molecular mechanisms of mTOR-mediated translational control | Q29615529 | ||
| Drug addiction, dysregulation of reward, and allostasis | Q29616741 | ||
| Proteomics. Tissue-based map of the human proteome | Q29617248 | ||
| STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data | Q30002336 | ||
| The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions | Q30537652 | ||
| The development and maintenance of drug addiction | Q30560436 | ||
| The addicted human brain: insights from imaging studies | Q30794301 | ||
| The role of the endogenous cannabinoid system in drug addiction | Q33344540 | ||
| Gap junction blockers: a potential approach to attenuate morphine withdrawal symptoms | Q33586541 | ||
| mTORC1 inhibition in the nucleus accumbens 'protects' against the expression of drug seeking and 'relapse' and is associated with reductions in GluA1 AMPAR and CAMKIIα levels. | Q33620587 | ||
| Cocaine self-administration in dopamine-transporter knockout mice | Q33858028 | ||
| The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. | Q33940362 | ||
| Cocaine modulates mammalian circadian clock timing by decreasing serotonin transport in the SCN. | Q34006034 | ||
| Serotonin Receptors – From Molecular Biology to Clinical Applications | Q34143560 | ||
| NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia | Q34149624 | ||
| Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence. | Q34200260 | ||
| Role for mammalian target of rapamycin complex 1 signaling in neuroadaptations underlying alcohol-related disorders | Q34358701 | ||
| Synaptic plasticity and drug addiction | Q34386424 | ||
| Cocaine-induced expression changes of axon guidance molecules in the adult rat brain | Q34390929 | ||
| Neurobiology of addiction: a neurocircuitry analysis | Q34535855 | ||
| Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits | Q34656312 | ||
| The role of acetylcholine in cocaine addiction. | Q34700186 | ||
| Actin cytoskeleton regulation in neuronal morphogenesis and structural plasticity | Q34762533 | ||
| Methylphenidate and μ opioid receptor interactions: a pharmacological target for prevention of stimulant abuse. | Q35016913 | ||
| Chemogenomics knowledgebased polypharmacology analyses of drug abuse related G-protein coupled receptors and their ligands. | Q35102561 | ||
| BalestraWeb: efficient online evaluation of drug-target interactions | Q35240181 | ||
| New medications for drug addiction hiding in glutamatergic neuroplasticity | Q35333393 | ||
| AKT signaling pathway in the nucleus accumbens mediates excessive alcohol drinking behaviors. | Q35587067 | ||
| Sigma-1 receptor directly interacts with Rac1-GTPase in the brain mitochondria | Q35617941 | ||
| An emerging role for the Mammalian target of rapamycin in "pathological" protein translation: relevance to cocaine addiction | Q35738367 | ||
| Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves | Q35874165 | ||
| Function of opioids in the enteric nervous system | Q35882827 | ||
| Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis. | Q35985429 | ||
| Cocaine-mediated microglial activation involves the ER stress-autophagy axis. | Q36111649 | ||
| Rapamycin attenuates the expression of cocaine-induced place preference and behavioral sensitization | Q36406346 | ||
| Enhancing Autophagy with Drugs or Lung-directed Gene Therapy Reverses the Pathological Effects of Respiratory Epithelial Cell Proteinopathy. | Q36444154 | ||
| Molecular mechanisms of opioid receptor-dependent signaling and behavior | Q36974487 | ||
| A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine. | Q37029832 | ||
| Spine dynamics and synapse remodeling during LTP and memory processes. | Q37131133 | ||
| Role of IGF1R(+) MSCs in modulating neuroplasticity via CXCR4 cross-interaction | Q37227786 | ||
| Genome-wide gene-set analysis for identification of pathways associated with alcohol dependence. | Q37372800 | ||
| Innate immune memory and homeostasis may be conferred through crosstalk between the TLR3 and TLR7 pathways | Q37380130 | ||
| KEGG: new perspectives on genomes, pathways, diseases and drugs | Q37556832 | ||
| Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects. | Q37671995 | ||
| Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor | Q37680254 | ||
| The endocannabinoid system and the brain | Q38026949 | ||
| Emerging roles of actin cytoskeleton regulating enzymes in drug addiction: actin or reactin'? | Q38083388 | ||
| mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse | Q38199194 | ||
| Bidirectional Synaptic Structural Plasticity after Chronic Cocaine Administration Occurs through Rap1 Small GTPase Signaling. | Q38267155 | ||
| Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. | Q38332823 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | pleiotropy | Q1134884 |
| P577 | publication date | 2019-03-08 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Quantitative Systems Pharmacological Analysis of Drugs of Abuse Reveals the Pleiotropy of Their Targets and the Effector Role of mTORC1 | |
| P478 | volume | 10 |
| Q92643628 | Domain-mediated interactions for protein subfamily identification |
| Q92763088 | Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology |
| Q90715435 | QuartataWeb: integrated chemical-protein-pathway mapping for polypharmacology and chemogenomics |
Search more.